Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
Publisher
Clinical Neuropharmacology(1)
Movement Disorders(1)
Parkinsonism and Related Disorders(1)
Value in Health(1)
Área temáticas
Problemas sociales y servicios a grupos(4)
Enfermedades(3)
Grupos de personas(2)
Medicina y salud(2)
Ginecología, obstetricia, pediatría, geriatría(1)
Origen
scopus(4)
A multi center comparative study of impulse control disorder in Latin American patients with Parkinson disease
ArticleAbstract: Objectives: Impulse control disorder (ICD) is a common adverse effect in patients with Parkinson disPalabras claves:Dopamine agonists, Impulse control disorder, Latin American, Mate, Parkinson DiseaseAutores:Aldinio V., Araoz N., Bernal O., Farret M., Gómez C., Micheli F., Montilla V., Serrano Dueñas MarcosFuentes:googlescopusCross-cultural evaluation of the modified Parkinson psychosis rating scale across disease stages
ArticleAbstract: This study assessed the psychometric attributes of the modified Parkinson Psychosis Rating Scale (mPPalabras claves:CISI-PD, Parkinson's Disease, PPRS, PsychosisAutores:Carod-Artal F.J., Martínez-Martín P., Micheli F., Rodriguez-Blazquez C., Serrano Dueñas Marcos, Virués-Ortega J.Fuentes:googlescopusCross-cultural validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial questionnaire (SCOPA-PS) in four Latin American countries
ArticleAbstract: Objective: To conduct a cross-national validation of the Scales for Outcomes in Parkinson's Disease-Palabras claves:CISI-PD, Health-related quality of life, Parkinson's Disease, PDQ-39, SCOPA-PSAutores:Carod-Artal F.J., Martínez-Martín P., Meza-Rojas G., Micheli F., Ruiz-Galeano G., Serrano Dueñas Marcos, Velázquez C., Virués-Ortega J.Fuentes:googlescopusAdherence to treatment in Parkinson's disease: A multicenter exploratory study with patients from six Latin American countries
ArticleAbstract: Background: Adherence to treatment in Parkinson's disease (PD) is compromised due to the need for muPalabras claves:Decision-making, FACTORS, medication, Nonadherence, Parkinson DiseaseAutores:Aguilar-Alvarado C.M., Álvarez-Villalobos N.A., Bernal O., Castro G.S., Estrada-Bellmann I., García Fernández C.L., Giugni J.C., González-Usigli H.A., Leal-Ortega R., Martínez-Hernández H.R., Mejía-Rojas K.K., Meléndez-Flores J.D., Micheli F., Miranda-Cabezas M., Mori N., Otero-Cerdeira E., Pecci C., Raina G.B., Sáenz-Farret M., Serrano Dueñas Marcos, Zúñiga-Ramírez C.Fuentes:googlescopus